Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment of Cytokine Storm Syndrome in Covid-19

NCT04362111 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT04362111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04362111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment of Cytokine Storm Syndrome in Covid-19
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2020
Completion date
June 1, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, cytokine storm